Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4583 Monkeypox Concept

Not Yet Opened 04-30 16:00:00 EDT

1,826.71

+26.99

+1.50%

High1,845.80	Low1,789.77	Vol23.02M
Open1,792.47	D1 Closing1,799.72	Amplitude3.11%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O1.29B	T/O Rate--	Tradable Shares0.00
P/B4.353349	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1826.7058,"timestamp":1777579199999,"preClose":1799.7151,"halted":0,"volume":23017704,"delay":0,"changeRate":0.014997,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":26.990723,"latestTime":"04-30 16:00:00 EDT","open":1792.4735,"high":1845.7957,"low":1789.7695,"amount":1285676345.805847,"amplitude":0.031131,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1777642200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.353349,"peRate":34.087333,"turnoverRate":0.008527,"increases":7,"decrements":2,"flats":1,"marketCap":202323037065.75,"floatMarketCap":201483424510.4375},"requestUrl":"/m/hq/s/BK4583/wiki","defaultTab":"wiki","newsList":[{"id":"2632615342","title":"Gilead publishes update to financial calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2632615342","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632615342?lang=en_us&edition=fundamental","pubTime":"2026-05-01 18:00","pubTimestamp":1777629617,"startTime":"0","endTime":"0","summary":"Gilead executives will speak at BofA Securities Health Care Conference on May 12.RBC Capital Markets Global Healthcare Conference scheduled for May 19.Bernstein Annual Strategic Decisions Conference set for May 28; Goldman Sachs Annual Global Healthcare Conference set for June 9.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDLb7tlV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","LU0306807586.USD","LU2471134952.CNY","BK4568","LU0106831901.USD","LU1201861249.SGD","LU0122379950.USD","LU0648000940.SGD","LU0052756011.USD","BK4532","GILD","LU1061106388.HKD","LU1880398471.USD","LU0234572021.USD","LU1057294990.SGD","LU1934455194.USD","LU0109394709.USD","LU0061475181.USD","LU1894683348.USD","LU1674673691.USD","LU0058720904.USD","LU2237443549.SGD","LU2237443895.HKD","BK4583","IE0001KFT4U8.USD","LU2471134523.USD","LU0823416689.USD","GSX","IE0004091025.USD","LU0130103400.USD","LU0965509101.SGD","BK4207","IE00B19Z3581.USD","LU0098860793.USD","BK4553","IE00BLSP4452.SGD","LU2468319806.SGD","LU1868837300.USD","LU1883839398.USD","LU1778281490.HKD","LU1280957306.USD","BAC","LU1718418525.SGD","IE00BKVL7J92.USD","BK4559","BK4533","LU1023059063.AUD","LU0149725797.USD","IE00B3T34201.USD","LU2129689514.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632692940","title":"Gilead Advances HIV And Oncology Pipeline As Shares Trade Below Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2632692940","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632692940?lang=en_us&edition=fundamental","pubTime":"2026-05-01 13:12","pubTimestamp":1777612325,"startTime":"0","endTime":"0","summary":"Gilead Sciences (NasdaqGS:GILD) received FDA acceptance and priority review for its New Drug Application for a once daily HIV regimen.\nThe company also completed its acquisition of Arcellx, gaining full control of a multiple myeloma CAR T cell therapy program.\nBoth developments relate to core franchises for Gilead, HIV and oncology, and come as the company continues to focus on therapies for serious diseases.\n\n\nGilead is widely associated with antiviral treatments, including HIV therapies,...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-advances-hiv-and-oncology-pipeline-as-shares-trade-be","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-advances-hiv-and-oncology-pipeline-as-shares-trade-be","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4550","LU0289739699.SGD","BK4578","BK4532","LU0823416689.USD","LU1934455277.USD","LU1023059063.AUD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU1430594728.SGD","LU1934455194.USD","BK4139","LU1037948541.HKD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU0882574055.USD","BK4566","LU2324357040.USD","LU1061106388.HKD","BK4585","GILD","IE00B19Z3581.USD","LU0965509101.SGD","SG9999015952.SGD","LU1585245621.USD","LU0965509283.SGD","LU0965508806.USD","LU0234570918.USD","BK4588","LU1037948897.HKD","IE0002270589.USD","BK4583","LU1066053197.SGD","LU2087621335.USD","LU2112291526.USD","LU0122379950.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU0861579265.USD","SG9999015986.USD","LU0114720955.EUR","LU0058720904.USD","LU0965509010.AUD","LU1057294990.SGD","LU0109394709.USD","LU1934455863.HKD","IE00BKVL7J92.USD","BK4568","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632615660","title":"Emergent BioSolutions Posts Weak Q1 Results Amid Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=2632615660","media":"TIPRANKS","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632615660?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:21","pubTimestamp":1777587697,"startTime":"0","endTime":"0","summary":"Emergent Biosolutions ( ($EBS) ) has issued an announcement. On April 30, 2026, Emergent BioSolutions reported first-quarter 2026 results showing t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/emergent-biosolutions-posts-weak-q1-results-amid-turnaround?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/emergent-biosolutions-posts-weak-q1-results-amid-turnaround?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632766444","title":"DaVita Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2632766444","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632766444?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:16","pubTimestamp":1777583760,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of DaVita Inc.  advanced 2.07% to $155.14 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 1.02% to 7,209.01 and the Dow Jones Industrial Average  rising 1.62% to 49,652.14.This was the stock's third consecutive day of gains.DaVita Inc. closed 2.68% below its 52-week high of $159.42, which the company achieved on March 2nd.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as UnitedHealth Group Inc.  fell 0.07% to $370.48, Icon PLC  rose 1.86% to $118.33, and Quest Diagnostics Inc.  rose 2.58% to $194.20.Trading volume  remained 32,104 below its 50-day average volume of 774,000.Data source: Dow Jones Market Data, FactSet. Data compiled April 30, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently fro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930490.SGD","LU0289960550.SGD","LU0310799852.SGD","LU0354030438.USD","LU0823416689.USD","LU0949170772.SGD","LU1691799644.USD","LU1791710582.SGD","LU1934455277.USD","LU2236285917.USD","LU2491049909.HKD","LU0211327993.USD","IE00B7SZLL34.SGD","LU0107464264.USD","LU0426412945.USD","LU0511384066.AUD","LU1153585028.USD","LU0528227936.USD","LU2271345857.HKD","IE00B19Z9Z06.USD","LU1261432733.SGD","IE00BZ1G4Q59.USD","LU0057025933.USD","LU0882574055.USD","SGXZ51526630.SGD","LU0823417737.USD","BK4566","SG9999001176.USD","LU1061106388.HKD","LU1720051017.SGD","LU0912757837.SGD","IE00BKPKM429.USD","SG9999002224.SGD","SG9999013999.USD","IE00BJJMRZ35.SGD","LU2133065610.SGD","LU0187121727.USD","LU1814569148.SGD","LU2506952170.USD","LU0238689110.USD","LU1732799900.SGD","LU0672654240.SGD","LU1496350502.SGD","LU0052756011.USD","LU1983299246.USD","LU0310800379.SGD","LU1037948897.HKD","IE00BZ9MQY76.HKD","IE00BFSS7M15.SGD","IE0002270589.USD","IE0005OL40V9.USD","LU0077335932.USD","LU2112291526.USD","SG9999018865.SGD","LU0994945656.USD","LU1674673691.USD","LU1003077747.HKD","IE00BJT1NW94.SGD","LU0158827948.USD","IE0002141913.USD","SG9999001176.SGD","LU0256863811.USD","LU2125154935.USD","LU0661504455.SGD","LU0058720904.USD","BK4121","IE00BJJMRX11.SGD","IE00B894F039.SGD","LU0211326755.USD","BK4154","LU0316494557.USD","LU0965509010.AUD","LU1043141123.HKD","LU2242649171.HKD","LU0472753341.HKD","LU0943347566.SGD","LU0175139822.USD","LU1718418525.SGD","LU2211815571.USD","LU2506952097.USD","LU1506573853.SGD","LU2362540622.SGD","LU0426417589.USD","IE00B19Z9505.USD","LU0251132253.USD","IE00BFSS8Q28.SGD","SGXZ31699556.SGD","LU0787776722.HKD","LU0889566641.SGD","LU1854104046.USD","LU0353189680.USD","IE00BJJMRY28.SGD","LU2111349929.HKD","SGXZ57979304.SGD","IE00B19Z3581.USD","LU1551013342.USD","IE00B19Z8W00.USD","LU2089283258.USD","LU2244417387.USD","SGXZ99366536.SGD","LU0203345920.USD","LU0097036916.USD","LU1988902786.USD","IE00B775H168.HKD","IE00BN29S564.USD","LU0708995401.HKD","LU1267930573.SGD","LU2023251221.USD","SGXZ81514606.USD","LU1720051108.HKD","LU1035773651.USD","LU2461242641.AUD","LU1732800096.USD","LU0122379950.USD","LU1267930730.SGD","LU1548497426.USD","LU2360032135.SGD","LU1267930227.SGD","LU0158827781.USD","LU0353189763.USD","LU2265009873.SGD","LU0289961442.SGD","LU1057294990.SGD","DVA","LU2087625088.SGD","LU0689472784.USD","BK4534","LU1778281490.HKD","LU2362541273.HKD","LU2028103732.USD","BK4532","LU0432979614.USD","SG9999014914.USD","BK4567","LU1804176565.USD","LU1934455194.USD","LU2491050071.SGD","LU1037948541.HKD","IE00B7KXQ091.USD","LU0029864427.USD","IE00B19Z8X17.USD","LU0456855351.SGD","LU1670628061.USD","LU0211328371.USD","LU2552382132.HKD","UNH","LU0557290698.USD","LU1670627923.USD","LU0203347892.USD","LU2362541513.USD","BK4585","LU0354030511.USD","LU0342679015.USD","LU1121112475.USD","LU0011850046.USD","LU2506951958.HKD","LU0820562030.AUD","LU1914381329.SGD","SG9999014898.SGD","BK4533","IE00B2B36J28.USD","LU0289739343.SGD","LU1989771016.USD","LU0094547139.USD","LU1674673428.USD","LU2361044865.SGD","LU0738911758.USD","LU0109391861.USD","LU0728928796.USD","LU1066053197.SGD","LU0345770308.USD","LU0496365809.HKD","LU0976567544.SGD","LU0310800965.SGD","IE00B1XK9C88.USD","IE00B19Z3B42.SGD","IE00B4JS1V06.HKD","LU1066051498.USD","LU2347655156.SGD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU2089284900.SGD","LU1066051225.USD","LU0795875169.SGD","LU0128525689.USD","IE0004445015.USD","LU2357305700.SGD","LU0114720955.EUR","UNHW","LU1043141396.HKD","IE00BKVL7J92.USD","LU0289739699.SGD","LU0198837287.USD","LU1023059063.AUD","IE00BSNM7G36.USD","LU0417517546.SGD","LU0266013472.USD","LU0211326839.USD","UNHG","LU1323610961.USD","LU0553294199.USD","LU0048584097.USD","LU1291159041.SGD","LU1791710400.SGD","SG9999014906.USD","IE00B19Z9P08.USD","LU2324357040.USD","LU0053666078.USD","LU1074936037.SGD","LU1267930813.SGD","SG9999018857.SGD","IE000M9KFDE8.USD","BK4581","LU0965509101.SGD","LU1066051811.HKD","LU1551013425.SGD","LU2264538146.SGD","LU2279689827.SGD","LU0950375773.USD","IE00BFXG1179.USD","LU0128525929.USD","LU2491050154.USD","LU0069063385.USD","LU0792757196.USD","LU2552382215.SGD","SG9999002232.USD","LU1064131342.USD","LU0965509283.SGD","LU2552382058.USD","LU0345770993.USD","BK4196","LU0965508806.USD","LU0234572021.USD","IE0004445239.USD","IE00BFTCPJ56.SGD","LU0545039389.USD","LU1119994496.HKD","LU2125154778.USD","BK4588","LU0820561909.HKD","IE00BWXC8680.SGD","LU2089984988.USD","BK4583","LU2361044949.HKD","LU2506951875.HKD","SG9999014880.SGD","LU0320765059.SGD","LU1983260115.SGD","LU2361045086.USD","LU0149725797.USD","LU0861579265.USD","IE0009355771.USD","LU0079474960.USD","LU0683600562.USD","LU1084165304.USD","BK4559","LU0708994859.HKD","SG9999017495.SGD","LU0795875086.SGD","LU0823417653.USD","LU0820561818.USD","LU1069347547.HKD","LU1854103824.USD","LU1934455863.HKD","IE00B1BXHZ80.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632661540","title":"Emergent BioSolutions Q1 Revenue USD 156.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2632661540","media":"Reuters","labels":["dataReport","merge","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632661540?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:44","pubTimestamp":1777581859,"startTime":"0","endTime":"0","summary":"Apr 30 (Reuters) - Emergent BioSolutions Q1 adjusted net income USD 11.9 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 30-APR-202620:30:47.37 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nRSD5MNtn2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,merge,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632694966","title":"Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2632694966","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632694966?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:35","pubTimestamp":1777581300,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 1.55% to $130.84 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 1.02% to 7,209.01 and the Dow Jones Industrial Average  rising 1.62% to 49,652.14.Gilead Sciences Inc. closed 16.82% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 1.10% to $229.85, Pfizer Inc.  rose 1.68% to $26.70, and Abbott Laboratories  fell 0.59% to $90.79.Trading volume  eclipsed its 50-day average volume of 6.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 30, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","IE00BGHQF631.EUR","LU0965509010.AUD","LU2430703251.USD","LU1023059063.AUD","LU2087621335.USD","LU0820562030.AUD","BK4585","LU0868494617.USD","IE0002270589.USD","LU2129689431.USD","LU0456855351.SGD","BK4583","LU1059921491.USD","LU1883839398.USD","LU1244550221.USD","LU0792757196.USD","BK4568","LU0306806265.USD","LU1043141396.HKD","IE00B7SZLL34.SGD","LU1280957306.USD","LU1894683264.USD","LU0225771236.USD","LU1674673428.USD","LU1057294990.SGD","LU1914381329.SGD","LU2505996509.AUD","BK4534","LU0683600562.USD","LU2430703178.SGD","LU0210528500.USD","BK4533","LU0345769631.USD","LU1162221912.USD","LU0787776722.HKD","LU2324357040.USD","BK4139","LU1221951046.USD","LU1934455277.USD","BK4550","LU0795875169.SGD","LU1551013342.USD","LU2129689514.USD","LU1839511570.USD","IE000WAW04H5.SGD","IE000BZT7R73.USD","LU0321505439.SGD","LU0882574055.USD","LU1551013425.SGD","SG9999011175.SGD","LU0985481810.HKD","LU0225284248.USD","LU1983299246.USD","IE0034235303.USD","IE00BLSP4239.USD","LU0985320562.USD","IE000SO60NU8.SGD","LU0466842654.USD","LU1032466523.USD","LU2471134523.USD","LU0889566641.SGD","LU2756315664.SGD","LU0203345920.USD","BK4532","LU0266013472.USD","LU1732799900.SGD","LU0234572021.USD","LU0321505868.SGD","IE00B3PB1722.GBP","LU0320765646.SGD","LU0122379950.USD","LU0432979614.USD","LU0640476718.USD","BK4578","LU1585245621.USD","SG9999002224.SGD","LU1989763690.USD","IE000F7OJYX1.SGD","IE00BFTCPJ56.SGD","LU0861579265.USD","LU2750360641.GBP","LU1196500208.SGD","LU0345770308.USD","LU1894683348.USD","LU2592432038.USD","LU0795875086.SGD","LU2347655156.SGD","LU0426412945.USD","IE00BJJMRZ35.SGD","LU2023250330.USD","GILD","LU0820561818.USD","IE00BLSP4452.SGD","SG9999001440.SGD","LU0098860793.USD","BK4599","LU0114720955.EUR","LU1718418525.SGD","LU0070217475.USD","LU0109394709.USD","SG9999002232.USD","LU2211815571.USD","LU2430703095.HKD","LU2505996681.GBP","LU0170899867.USD","LU2237957902.USD","IE00BZ1G4Q59.USD","LU1074936037.SGD","LU0289739699.SGD","LU1267930813.SGD","LU1496350502.SGD","LU1066051225.USD","LU0965509283.SGD","LU1721429402.USD","IE00B19Z3B42.SGD","SG9999015945.SGD","BK4504","LU1043141123.HKD","LU0823416689.USD","SG9999003800.SGD","IE00BFXG1179.USD","LU0053666078.USD","LU1121112475.USD","LU2129689605.HKD","IE00BVYPNV92.GBP","BK4082","BK4559","LU2471134879.HKD","LU1066051498.USD","LU0058720904.USD","LU2750360997.AUD","IE0002141913.USD","IE00B1BXHZ80.USD","SGXZ41872573.SGD","LU0820561909.HKD","SG9999001176.SGD","SGXZ23171101.USD","SGXZ57979304.SGD","LU2112291526.USD","LU0689472784.USD","LU0965508806.USD","IE00BBT3K403.USD","LU1261432733.SGD","LU1732800096.USD","LU1037948897.HKD","IE00BDGV0183.EUR","LU1934455863.HKD","IE00B3T34201.USD","LU1244550494.USD","SG9999015978.USD","LU0345770993.USD","LU0912757837.SGD","LU1778281490.HKD","IE00BKVL7J92.USD","LU0345769128.USD","LU2756315318.SGD","IE0009355771.USD","BK4007","IE00BN8TJ469.HKD","LU1061106388.HKD","LU2468319806.SGD","LU1929549753.HKD","LU1629891620.HKD","IE00BSNM7G36.USD","IE00BVYPNW00.USD","SG9999013999.USD","LU2089984988.USD","IE000M9KFDE8.USD","LU0943347566.SGD","BK4581","SG9999015952.SGD","SG9999004303.SGD","LU1145028129.USD","SG9999001176.USD","LU1674673691.USD","LU2602419157.SGD","IE000MB6IJN5.SGD","IE00B19Z3581.USD","LU2487616109.SGD","LU1721429741.USD","LU1935042991.SGD","LU1244550577.SGD","LU1221951129.SGD","LU0306807586.USD","BK4592","SG9999015986.USD","LU0426417589.USD","IE0001KFT4U8.USD","LU1032955483.USD","LU1430594728.SGD","LU2471134796.USD","IE00B42XCP33.USD","LU1506573853.SGD","LU1066051811.HKD","LU2237957811.SGD","IE00B4R5TH58.HKD","LU0964807845.USD","LU2133065610.SGD","IE00BJT1NW94.SGD","LU0965509101.SGD","LU2896262040.SGD","LU1571399168.USD","IE00B2B36J28.USD","LU1989763427.SGD","LU2213496289.HKD","LU0889565916.HKD","LU1037948541.HKD","BK4588","LU1691799644.USD","LU0124676726.USD","LU2471134952.CNY","LU1066053197.SGD","LU0994945656.USD","LU0210536198.USD","LU0203347892.USD","LU0320765992.SGD","LU0689626769.HKD","LU1934455194.USD","IE0000B7K699.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632669670","title":"Emergent BioSolutions Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2632669670","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632669670?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:30","pubTimestamp":1777581002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA6FFKJ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBS","BK4583","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632669191","title":"Emergent BioSolutions Outlook FY Adjusted Net Income USD 45-65 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2632669191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632669191?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:30","pubTimestamp":1777581002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLXFCB379:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4583","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660669","title":"Emergent BioSolutions Q1 Gross Margin 41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632660669?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:30","pubTimestamp":1777581002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLXFCB379:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBS","BK4583","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632265018","title":"3 Promising Penny Stocks With Market Caps Under $200M","url":"https://stock-news.laohu8.com/highlight/detail?id=2632265018","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632265018?lang=en_us&edition=fundamental","pubTime":"2026-05-01 01:05","pubTimestamp":1777568718,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the market has remained flat, yet it is up 28% over the past year with earnings forecasted to grow by 16% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for growth at lower price points, especially when backed by strong balance sheets and solid fundamentals. This article explores several penny stocks that stand out as hidden gems, potentially offering both stability and upside in today's market landscape.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nysemkt-xtnt/xtant-medical-holdings/news/3-promising-penny-stocks-with-market-caps-under-200m-9","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nysemkt-xtnt/xtant-medical-holdings/news/3-promising-penny-stocks-with-market-caps-under-200m-9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1046422090.SGD","BK4583","FINV","BK4189","MAPS","NAGE","RGP","BK4134","VFF","BK4579","BK4539","BK4198","III","LU0049112450.USD","BK4161","BABB","SIGA","BK4183","BK4166","BK4191","XTNT","BK4531","BK4209","BK4023","NEPH","BK4121","BK4007","BK4123","CRCT","LU1235295612.USD","LX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632654403","title":"Labcorp lifts full‑year forecast as diagnostics business stays resilient","url":"https://stock-news.laohu8.com/highlight/detail?id=2632654403","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632654403?lang=en_us&edition=fundamental","pubTime":"2026-05-01 00:16","pubTimestamp":1777565818,"startTime":"0","endTime":"0","summary":"UPDATE 1-Labcorp lifts fullyear forecast as diagnostics business stays resilientQ1 adjusted operating margin expands to 14.4%Posts revenue, adjusted EPS above estimatesCEO Adam Schechter highlights gr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nL4N41D23B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LH","BK4550","BK4588","LU0950375773.USD","LU2506952097.USD","LU2237438978.USD","LU2506952170.USD","EVR","LU0048573561.USD","LU0823417737.USD","BK4567","LU0823417653.USD","LU0742534661.SGD","BK4583","LU1854104046.USD","LU0251142724.SGD","BK4196","LU2506951875.HKD","DGX","LU0006061336.USD","LU1854103824.USD","LU0251131958.USD","LU2506951958.HKD","LU1059921491.USD","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631655528","title":"Emergent BioSolutions receives Singapore regulatory approval for ACAM2000","url":"https://stock-news.laohu8.com/highlight/detail?id=2631655528","media":"TIPRANKS","labels":["policyRegulatory","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631655528?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:58","pubTimestamp":1777557539,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions (EBS) announced that Singapore’s Health Sciences Authority has approved an expanded indication for ACAM2000 to include preven...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/emergent-biosolutions-receives-singapore-regulatory-approval-for-acam2000-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/emergent-biosolutions-receives-singapore-regulatory-approval-for-acam2000-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631630067","title":"BRIEF-Emergent Biosolutions Receives Approval From Singapore Health Sciences Authority","url":"https://stock-news.laohu8.com/highlight/detail?id=2631630067","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631630067?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:10","pubTimestamp":1777554610,"startTime":"0","endTime":"0","summary":"BRIEF-Emergent Biosolutions Receives Approval From Singapore Health Sciences Authority April 30 (Reuters) - Emergent BioSolutions Inc EBS.N:EMERGENT BIOSOLUTIONS RECEIVES APPROVAL FROM SINGAPORE HEALT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41D0LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631634881","title":"Labcorp raises full-year forecasts on steady diagnostics demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2631634881","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631634881?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:59","pubTimestamp":1777550344,"startTime":"0","endTime":"0","summary":"Labcorp raises full-year forecasts on steady diagnostics demand April 30 (Reuters) - Labcorp LH.N raised its full-year profit and revenue forecast on Thursday after posting quarterly results above exp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nL4N41D1G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823417737.USD","LU1059921491.USD","LU2506951958.HKD","LU2237438978.USD","LU1854103824.USD","LU0950375773.USD","BK4196","BK4585","LU2506952097.USD","LU0823417653.USD","LU2506952170.USD","LU0048573561.USD","LU0251131958.USD","LU2506951875.HKD","BK4567","LU0742534661.SGD","BK4583","LU0251142724.SGD","LU0006061336.USD","BK4588","LH","DGX","LU1854104046.USD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631314746","title":"Singapore HSA approves Emergent ACAM2000 vaccine label expansion to include mpox","url":"https://stock-news.laohu8.com/highlight/detail?id=2631314746","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631314746?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:55","pubTimestamp":1777550117,"startTime":"0","endTime":"0","summary":"Singapore Health Sciences Authority cleared expanded indication for Emergent BioSolutions ACAM2000 to cover mpox prevention in high-risk adults.Decision widens Singapore authorization beyond smallpox, supporting outbreak use when alternative vaccines are unavailable or contraindicated.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL99GgZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BN0W2V16.EUR","SG9999014005.SGD","SG9999014013.SGD","BK4585","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","EBS","IE00BGHQF748.EUR","NDAQ","BK4583","IE00BN0W2W23.USD","SG9999014021.USD","LU2095319765.USD","BK4139","LU2210149790.SGD","BK4112","LU0314104364.USD","SG9999014039.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631639760","title":"Emergent BioSolutions shareholders approved amendment to increase stock incentive plan shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2631639760","media":"Reuters","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631639760?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:36","pubTimestamp":1777548997,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions held its annual shareholder meeting on April 29, 2026.Investors authorized an amendment to Emergent’s stock incentive plan to increase shares available for equity awards.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emergent BioSolutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL9kcZnL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631639634","title":"SIGA Technologies to host business update call after first-quarter results","url":"https://stock-news.laohu8.com/highlight/detail?id=2631639634","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631639634?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:30","pubTimestamp":1777548615,"startTime":"0","endTime":"0","summary":"SIGA Technologies will host webcast conference call May 7, 2026 at 4:30 p.m. ET to provide business update following release of first-quarter 2026 financial results.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL6BPkDC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014039.USD","BK4583","BK4112","NDAQ","IE00B64PRP62.GBP","SIGA","IE00BKPKM429.USD","SG9999014021.USD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","BK4588","LU2210149790.SGD","SG9999014005.SGD","BK4007","IE00BN0W2W23.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631636374","title":"Kymera Q1 revenue jumps on Gilead milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636374","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636374?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:09","pubTimestamp":1777547380,"startTime":"0","endTime":"0","summary":"Kymera Q1 revenue jumps on Gilead milestoneOverviewUS biopharma firm's Q1 revenue rose sharply, beating analyst expectationsNet loss widened in Q1 as R&D and G&A expenses increasedCompany received $45","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nL1N41D0NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU2324357040.USD","LU2087621335.USD","SG9999015952.SGD","LU0861579265.USD","LU1057294990.SGD","LU1674673428.USD","LU1674673691.USD","BK4532","LU0965508806.USD","BK4588","BK4139","IE00B19Z3581.USD","LU2089984988.USD","IE00BSNM7G36.USD","LU0234570918.USD","SG9999015945.SGD","IE00B19Z3B42.SGD","LU1066051498.USD","LU2112291526.USD","LU1778281490.HKD","LU1430594728.SGD","BK4550","LU1037948541.HKD","GILD","SG9999015986.USD","LU0965509010.AUD","KYMR","IE00B7SZLL34.SGD","LU0882574055.USD","LU1839511570.USD","BK4568","LU0965509101.SGD","LU0058720904.USD","LU1023059063.AUD","LU0122379950.USD","LU1066053197.SGD","LU0823416689.USD","LU1585245621.USD","LU0114720955.EUR","LU0965509283.SGD","LU1037948897.HKD","LU1061106388.HKD","LU0320765992.SGD","IE00BZ1G4Q59.USD","LU1571399168.USD","LU1934455277.USD","LU0889565916.HKD","BK4583","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631150346","title":"2 Things Matter Most in Picking Winning Stocks, Says This Market Pro -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2631150346","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631150346?lang=en_us&edition=fundamental","pubTime":"2026-04-30 12:30","pubTimestamp":1777523400,"startTime":"0","endTime":"0","summary":"Adam Parker, founder and CEO of Trivariate Research, has long been fascinated by the information that can be found in missing data. He studied the subject in graduate school, earning a doctorate in statistics, and then took his passion to Wall Street, where what isn't evident is often key.Parker was a top-ranked semiconductor analyst at Sanford C. Bernstein, and later global director of research, before becoming chief U.S. equity strategist and director of global quantitative research at Morgan Stanley. He subsequently ran a hedge fund, and launched Trivariate in 2021 to provide U.S. equity research to institutional clients, focusing on macro, fundamental, and quantitative variables, or the triple play implied by the firm's name. Last year, he launched Trivector Research, aimed at financial advisors and individual investors.Adam Parker: I have always been interested in empirically studying things. The common thread is analytical rigor. My firm is called Trivariate to reflect the three ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ9MQY76.HKD","LU0689626769.HKD","VGT","NOW","LU0348723411.USD","LU2381873111.SGD","LU1506573853.SGD","MCK","LU2111349929.HKD","LU0672654240.SGD","CAH","LU2089284900.SGD","LU0823417653.USD","BK4583","DGX","LU1923622614.USD","LU2112291526.USD","LU2324357040.USD","VHT","LU0109392836.USD","LU0823417737.USD","LU2023250843.SGD","BK4196","LU0058720904.USD","LU2089984988.USD","NOWL","IXJ","LU0820561818.USD","LU0048573561.USD","LU1934455194.USD","LU0689472784.USD","LU2028103732.USD","LU2506952097.USD","SG9999004303.SGD","LU0719512351.SGD","LU0289739699.SGD","LU1057294990.SGD","LU0082616367.USD","LU1989764664.SGD","LU1854103824.USD","LU0128525689.USD","LU1430594728.SGD","BK4608","IE00B19Z9P08.USD","COR","LU1923622291.USD","LU2023251221.USD","LU0861579265.USD","LU0265550946.USD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631352785","title":"Gilead CEO Daniel O'Day sells 10,000 shares for $1.29 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631352785","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631352785?lang=en_us&edition=fundamental","pubTime":"2026-04-30 05:54","pubTimestamp":1777499653,"startTime":"0","endTime":"0","summary":"Gilead Chairman and CEO Daniel Patrick O’Day sold 10,000 shares of common stock on April 28, 2026.Shares were sold at prices of USD 128.79 and USD 130.01.Beneficial ownership fell to 632,567 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL77xx86:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead CEO Daniel O'Day sells 10,000 shares for $1.29 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LU1037948541.HKD","SG9999015978.USD","LU1674673428.USD","LU1066051498.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","SG9999015952.SGD","LU0823416689.USD","LU0965509101.SGD","LU0234570918.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU2468319806.SGD","BK4578","BK4585","GILD","LU0289739699.SGD","SG9999015986.USD","LU1585245621.USD","BK4568","BK4566","BK4550","LU1934455277.USD","LU1430594728.SGD","BK4588","LU0882574055.USD","BK4583","LU1023059063.AUD","LU0965508806.USD","LU0320765992.SGD","IE00B19Z3581.USD","LU0965509010.AUD","LU0058720904.USD","SG9999015945.SGD","LU0965509283.SGD","BK4532","LU1037948897.HKD","LU1934455863.HKD","BK4139","IE0002270589.USD","LU1778281490.HKD","LU1839511570.USD","LU2089984988.USD","LU1674673691.USD","LU1066053197.SGD","LU2112291526.USD","IE00B3T34201.USD","LU0861579265.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0144},{"period":"1month","weight":0.1051},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.0537},{"period":"1year","weight":0.296},{"period":"ytd","weight":0.0539}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4583","nameEN":"BK4583"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Monkeypox Concept,BK4583,Monkeypox Concept股票,Monkeypox Concept股票老虎,Monkeypox Concept股票老虎国际,Monkeypox Concept行情,Monkeypox Concept股票行情,Monkeypox Concept股价,Monkeypox Concept股市,Monkeypox Concept股票价格,Monkeypox Concept股票交易,Monkeypox Concept股票购买,Monkeypox Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction